Can Adenylate Cyclase Serve as a Therapeutic Target?
Yes, adenylate cyclase is a promising therapeutic target. By understanding its role in disease mechanisms, scientists can develop drugs that modulate its activity. This approach is being explored in conditions like heart failure, where altered cAMP signaling is a key factor. Targeting adenylate cyclase could restore normal signaling and improve patient outcomes.
